The European Industrial Pharmacists Group (EIPG) elected a new Bureau members at its General Assembly in Madrid this May. Mrs. Anni Svala, Quality Director at Tamro has been elected President of EIPG for a three-year term.
A passionate, forward-thinking, and results-oriented Industrial Pharmacist (M.Sc. Pharm.), she is widely recognized as a dedicated and impact-driven quality executive with a strong track record in quality leadership, regulatory affairs, and influencing.
Svala has been actively involved in EIPG since 2009, when she began as Finland’s country delegate. In 2014, she was elected Vice President for Education and Careers, and since 2023, she has served as Vice President for European Affairs. Her long-standing dedication to the organisation reflects a deep understanding of EIPG’s mission and a strong commitment to advance the role of industrial pharmacy and pharmacists across Europe.
In her professional role, Svala serves as a member of the Executive Board, Quality Director, and Responsible Pharmacist at Tamro Corporation in Finland. Her leadership combines strategic foresight with a focus on operational excellence. She is known for her proactive and positive leadership style, as well as her dedication to mentoring and supporting young professionals.
About EIPG
The European Industrial Pharmacists Group (EIPG) is a European association representing the national professional organisations of pharmacists employed in the pharmaceutical or allied industries of the Member States of the European Union, the European Economic Area, or European countries having a mutual recognition agreement with the European Union on compliance control of regulated medicines.
Founded in 1966, EIPG has evolved alongside the European Union, consistently advocating for the professional development and recognition of industrial pharmacists. Registered in France as a non-profit organization, EIPG currently represents approximately 10,000 professionals working in the European pharmaceutical and allied industries.
EIPG is listed in the EU Transparency Register of the European Commission and is recognized as an eligible industry stakeholder by the European Medicines Agency (EMA).
